CRMD FY 2012 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$522M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$274,358

Balance Sheet

Total Assets

$1M

Total Liabilities

$2M

Stockholders' Equity

-$475,376

Cash & Equivalents

$835,471

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$7M	+58.0%
Net Income	-$3M	-$7M	+49.0%